Postbiotics in Metabolic Disorders
- Publisher's listprice GBP 110.00
-
52 552 Ft (50 050 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 10 510 Ft off)
- Discounted price 42 042 Ft (40 040 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
52 552 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 19 August 2025
- ISBN 9781041000082
- Binding Hardback
- No. of pages196 pages
- Size 254x178 mm
- Weight 520 g
- Language English
- Illustrations 13 Illustrations, color; 15 Line drawings, color; 14 Tables, black & white 688
Categories
Short description:
This book explores the role of postbiotics in human health, highlighting their benefits in cardiovascular disorders, cancer, and diabetes. It discusses their impact on immune modulation and metabolic disorders. This book is a useful resource for researchers and students of pharmacology and biotechnology.
MoreLong description:
This book discusses the role of postbiotics in human health. The initial chapter highlights the potential of postbiotics beyond traditional prebiotics and probiotics. Subsequent chapters present the beneficial effects on various health conditions, including cardiovascular disorders, cancer, diabetes, gestational diabetes, obesity, and mitochondrial disorders.
The book covers the role of postbiotics in immune system modulation and inflammation-mediated metabolic disorders. It also explores the interaction of postbiotics with gut microbiota, detailing molecular mechanisms and signaling pathways. In addition, it offers current and future perspectives on postbiotics in human health, addressing their role in managing insulin resistance, glucose metabolism, metabolic endotoxemia, and inflammation in type 2 diabetes. The text provides an in-depth analysis of the impact of postbiotics on non-alcoholic fatty liver disease (NAFLD), lipid profiles, and hypertension. In addition, the chapters:
1) Explore the promising concept of postbiotics and their potential beyond prebiotics and probiotics.
2) Examine the beneficial effects of postbiotics on cardiovascular health, cancer, diabetes, and other conditions.
3) Discuss the role of postbiotics in immune system modulation and inflammation-mediated metabolic disorders.
4) Cover the interaction of postbiotics with gut microbiota, highlighting molecular mechanisms and signaling pathways.
5) Analyze the current and future perspectives on postbiotics, including their impact on various metabolic disorders.
This book is a useful resource for researchers and students of pharmacology and biotechnology.
More
Table of Contents:
Chapter 1 Postbiotics: A promising Concept Beyond Pre-and Probiotics in Human Health. Chapter 2 Postbiotics: Beneficial impact on Cardiovascular Disorders. Chapter 3 Postbiotics in Cancer Treatment. Chapter 4 Postbiotics: Beneficial Impact on Diabetes. Chapter 5 Postbiotics: In Gestational Diabetes Mellitus. Chapter 6 Postbiotics: Beneficial impact on obesity. Chapter 7 Postbiotics: Beneficial Impact on Mitochondrial Disorders. Chapter 8 Postbiotics: Role in immune system modulation. Chapter 9 Postbiotics and Their Role in Modulating Inflammation-Driven Metabolic Disorders. Chapter 10 Postbiotics and Gut Microbiota: Gut Health and Oxidative Stress Modulation. Chapter 11 Postbiotic: Current and Future Perspectives in Human Health. Chapter 12 Postbiotics in Managing Insulin Resistance and Glucose Metabolism. Chapter 13 Postbiotics: in metabolic endotoxemia and inflammation in type 2 diabetes. Chapter 14 Postbiotics: In Non-Alcoholic Fatty Liver Disease. Chapter 15 Postbiotics: regulating lipid profiles and hypertension. Chapter 16 Postbiotics: Safety, efficacy and regulatory considerations.
More
Qurratulain Hyder on the Move: Crossing the Frontiers of Gender, Language, and Nation
36 912 HUF
33 960 HUF
